Who Owns Biovie

Our President and CEO Cuong Do discusses BioVie's pipeline and provides updates on our clinical trials in Parkinson's disease. BioVie Nasdaq BIVI is approaching a pivotal stretch with multiple clinical and regulatory milestones that investors should be. For biotech investors and healthcare innovators this New to The Street interview features BioVie Pharma leadership discussing a.

Neuroinflammation and insulin resistance are increasingly being studied as important drivers across multiple CNS disorders. Long COVID impacts millions of Americans and there are currently no approved treatments though researchers are increasingly. For biotech investors healthcare professionals and science enthusiasts this interview features Cuong Do President CEO of.

BioVie is poised for significant catalysts in 2023 including data read out from its Alzheimer's Phase 3 trial expected in Q3 2023. Amardeep Parmar from Bae HQ welcomes Devika Thapar Cofounder of Wilbe Amardeep Parmar.